Nuvectis Pharma, Inc. — Director's Dealing 2024

Jan 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2024-01-03

Reporting Person: Shemesh Shay (Chief Dev. & Ops. Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-03	Common Stock	A	130000	—	Acquired	1491955	Direct

Footnotes

F1: The restricted stock will vest according to the following schedule: one-third on each of 01/3/2025, 01/3/2026, and 01/3/2027.

F2: Includes 353,399 shares of restricted stock.